Kinematic aiming task: Measuring functional changes in hand and arm movements after botulinum toxin-A injections in children with spastic hemiplegia

American Journal of Physical Medicine and Rehabilitation

Volumn 86, Issue 7, 2007, Pages 538-547

  Rameckers, Eugene A A ^a,b,c,d,f   Speth, Lucianne A W M ^a,c   Duysens, Jacques ^b,f   Vles, J S Hans ^c   Smits Engelsman, Bouwien C M ^b,d,e,f  

^a Adelante Netherlands   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d AVANS UNIVERSITY OF APPLIED SCIENCES   (Netherlands)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f SINT MAARTENSKLINIEK   (Netherlands)

Author keywords

Ashworth scale; BTX A; Cerebral palsy; Kinematic aiming task; Spasticity; Tardieu scale; Upper limb

Indexed keywords

BOTULINUM TOXIN A;

ACCURACY; ADOLESCENT; ARM MOVEMENT; ARM MUSCLE; ARTICLE; ASHWORTH SCALE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ELBOW; FEMALE; HANDICAPPED CHILD; HEMIPLEGIA; HUMAN; KINEMATICS; MALE; MUSCLE CONTRACTION; MUSCLE FORCE; MUSCLE STRETCHING; MUSCLE TONE; RATING SCALE; REPRODUCIBILITY; SPASTICITY; TARDIEU SCALE; TASK PERFORMANCE; VOLUNTARY MOVEMENT; WRIST;

ADOLESCENT; BIOMECHANICS; BOTULINUM TOXIN TYPE A; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; ENDPOINT DETERMINATION; FEMALE; HEMIPLEGIA; HUMANS; MALE; MOTOR SKILLS; MUSCLE CONTRACTION; NEUROMUSCULAR AGENTS; RANGE OF MOTION, ARTICULAR; TASK PERFORMANCE AND ANALYSIS; UPPER EXTREMITY;

EID: 34250902913     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/PHM.0b013e31806dbc3c     Document Type: Article

References (36)

1. Hanna SE, Law MC, Rosenbaum PL, et al: Development of hand function among children with cerebral palsy: growth curve analysis for ages 16 to 70 months. Dev Med Child Neurol 2003;45:448-55
2. Gordon AM, Duff SV: Relation between clinical measures and fine manipulative control in children with hemiplegic cerebral palsy. Dev Med Child Neurol 1999;41:586-91
3. Smits-Engelsman BC, Rameckers EA, Duysens J: Muscle force generation and force control of finger movements in children with spastic hemiplegia during isometric tasks. Dev Med Child Neurol 2005;47:337-42
4. Ponten E, Friden J, Thornell LE, Lieber RL: Spastic wrist flexors are more severely affected than wrist extensors in children with cerebral palsy. Dev Med Child Neurol 2005;47:384-9
5. Kuhtz-Buschbeck JP, Sundholm LK, Eliasson AC, Forssberg H: Quantitative assessment of mirror movements in children and adolescents with hemiplegic cerebral palsy. Dev Med Child Neurol 2000;42:728-36
6. Steenbergen B, Meulenbroek RG, Rosenbaum DA: Constraints on grip selection in hemiparetic cerebral palsy: effects of lesional side, end-point accuracy, and context. Brain Res Cogn Brain Res 2004;19:145-59
7. Ashworth B: Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964;192:540-2
8. Held JP, Pierrot-Desseilligny E: Le bilan moteur central. In: Reeducation Motrice des Affections Neurologiques. Paris, JB Bailiere et fils, 1969, pp 31-42
9. Wasiak J, Hoare B, Wallen M: Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy. Cochrane Database Syst Rev 2004;(4):CD003469
10. Ostensjo S, Carlberg EB, Vollestad NK: Motor impairments in young children with cerebral palsy: relationship to gross motor function and everyday activities. Dev Med Child Neurol 2004;46:580-9
11. Desloovere K, Molenaers G, Feys H, Huenaerts C, Callewaert B, Walle PV: Do dynamic and static clinical measurements correlate with gait analysis parameters in children with cerebral palsy? Gait Posture 2006;24:302-13
12. Scholtes VA, Becher JG, Beelen A, Lankhorst GJ: Clinical assessment of spasticity in children with cerebral palsy: a critical review of available instruments. Dev Med Child Neurol 2006;48:64-73
13. Boyd RN, Graham JEA, Nattrass GR, Graham HK: Mediumterm response characterisation and risk factor analysis of botulinum toxin type A in the management of spasticity in children with cerebral palsy. Eur J Neurol 1999;6:S37-45
14. Damiano DL, Quinlivan JM, Owen BF, Payne P, Nelson KC, Abel MF: What does the Ashworth scale really measure and are instrumented measures more valid and precise? Dev Med Child Neurol 2002;44:112-8
15. Smeulders MJ, Kreulen M, Hage JJ, Huijing PA, van der Horst CM: Spastic muscle properties are affected by length changes of adjacent structures. Muscle Nerve 2005;32:208-15
16. Damiano DL, Laws E, Carmines DV, Abel MF: Relationship of spasticity to knee angular velocity and motion during gait in cerebral palsy. Gait Posture 2006;23:1-8
17. Boyd RN, Hays RM: Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review. Eur J Neurol 2001;8(suppl 5):1-20
18. Rose J, McGill KC: Neuromuscular activation and motorunit firing characteristics in cerebral palsy. Dev Med Child Neurol 2005;47:329-36
19. van Roon D, Steenbergen B, Hulstijn W: Reciprocal tapping in spastic hemiparesis. Clin Rehabil 2000;14:592-600
20. Wong V: Evidence-based approach of the use of botulinum toxin type A (BTX) in cerebral palsy. Pediatr Rehabil 2003;6:85-96
21. Speth LA, Leffers P, Janssen-Potten YJ, Vles JS: Botulinum toxin A and upper limb functional skills in hemiparetic cerebral palsy: a randomized trial in children receiving intensive therapy. Dev Med Child Neurol 2005;47:468-73
22. Hagberg B, Hagberg G, Olow I: The changing panorama of cerebral palsy in Sweden. VI. Prevalence and origin during the birth year period 1983-1986. Acta Paediatr 1993;82:387-93
23. Zancolli EA, Zancolli Ej: Surgical rehabilitation of the spastic upper limb in cerebral palsy. In: Lamb DW, ed. The Paralyzed Hand. Edinburgh, Churchill Livingstone, 1987, pp 153-60
24. Graham HK, Aoki KR, Autti-Ramo I, et al: Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture 2000;11:67-79
25. World Health Organisation: International classification of functioning, disability and health: ICF. Geneva, WHO, 2001
26. Scholtes VA, Dallmeyer AJ, Harlaar J, Becher JG: The SPAT: A Clinical Spasticity Assessment for Children with a Spastic Hemiparesis. Monaco, EACD, 2005
27. Horger MM: The reliability of goniometric measurements of active and passive wrist motions. Am J Occup Ther 1990;44:342-8
28. Smits-Engelsman BC, Rameckers EA, Duysens J: Late developmental deficits in force control in children with hemiplegia. Neuroreport 2004;15:1931-5
29. Jong de WP, Hulstijn W, Kosterman BJM, Smits-Engelsman BCM: Oasis: a new macro language for the experimental research of handwriting. In: Proceedings of the Seventh Handwriting Conference of the International Graphonomics Society, London, Ontario, 1995
30. Fitts PM: The information capacity of the human motor system in controlling the amplitude of movement. J Exp Psychol 1954;47:381-91
31. Smits-Engelsman BC, Swinnen SP, Duysens J: The advantage of cyclic over discrete movements remains evident following changes in load and amplitude. Neurosci Lett 2006;396:28-32
32. Koman LA, Mooney JF 3rd, Smith BP, Walker F, Leon JM: Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group. J Pediatr Orthop 2000;20:108-15
33. Corry IS, Cosgrove AP, Walsh EG, McClean D, Graham HK: Botulinum toxin A in the hemiplegic upper limb: a doubleblind trial. Dev Med Child Neurol 1997;39:185-93
34. Fehlings D, Rang M, Glazier J, Steele C: Botulinum toxin type A injections in the spastic upper extremity of children with hemiplegia: child characteristics that predict a positive outcome. Eur J Neurol 2001;8(suppl 5):145-9
35. Gordon AM, Charles J, Duff SV: Fingertip forces during object manipulation in children with hemiplegic cerebral palsy. II: bilateral coordination. Dev Med Child Neurol 1999;41:176-85
36. Gordon AM, Duff SV: Fingertip forces during object manipulation in children with hemiplegic cerebral palsy. I: anticipatory scaling. Dev Med Child Neurol 1999;41:166-75